DC-SIGN plays a stronger role than DCIR in mediating HIV-1 capture and transfer

Virology

Volumn 458-459, Issue 1, 2014, Pages 83-92

  Jin, Wei ^a,b   Li, Chang ^a,b   Du, Tao ^a   Hu, Kai ^a   Huang, Xin ^a,b   Hu, Qinxue ^a,c  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

C type lectin receptor; Capture; DC SIGN; DCIR; HIV 1; Transfer

Indexed keywords

CD209 ANTIGEN; DENDRITIC CELL IMMUNORECEPTOR; GLYCOPROTEIN GP 120; LECTIN RECEPTOR; TETRAMER; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CARBOHYDRATE RECOGNITION DOMAIN; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; VIRUS CELL INTERACTION; VIRUS TRANSMISSION;

C-TYPE LECTIN RECEPTOR; CAPTURE; DC-SIGN; DCIR; HIV-1; TRANSFER;

AMINO ACID SEQUENCE; BINDING SITES; CELL ADHESION MOLECULES; CELLS, CULTURED; DENDRITIC CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENETIC ENGINEERING; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC;

EID: 84899860613     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.04.016     Document Type: Article

References (75)

1. Abdiche Y., Malashock D., Pinkerton A., Pons J. Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet. Anal. Biochem. 2008, 377(2):209-217.
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673):245-252.
4. Baribaud F., Pohlmann S., Doms R.W. The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission. Virology 2001, 286(1):1-6.
5. Bates E.E., Fournier N., Garcia E., Valladeau J., Durand I., Pin J.J., Zurawski S.M., Patel S., Abrams J.S., Lebecque S., Garrone P., Saeland S. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 1999, 163:1973-1983.
6. Bloem K., Vuist I.M., van der Plas A.J., Knippels L.M., Garssen J., Garcia-Vallejo J.J., van Vliet S.J., van Kooyk Y. Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain. PLoS One 2013, 8(6):e66266.
7. Bobardt M.D., Chatterji U., Selvarajah S., Van der Schueren B., David G., Kahn B., Gallay P.A. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J. Virol. 2007, 81(1):395-405.
8. Boggiano C., Manel N., Littman D.R. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J. Virol. 2007, 81(5):2519-2523.
9. Cambi A., Beeren I., Joosten B., Fransen J.A., Figdor C.G. The C-type lectin DC-SIGN internalizes soluble antigens and HIV-1 virions via a clathrin-dependent mechanism. Eur. J. Immunol. 2009, 39(7):1923-1928.
10. + T cells. Science 1992, 257(5068):383-387.
11. Curtis B.M., Scharnowske S., Watson A.J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 1992, 89(17):8356-8360.
12. da Silva R.C., Segat L., Crovella S. Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission. Hum. Immunol. 2011, 72(4):305-311.
13. de Witte L., Bobardt M., Chatterji U., Degeest G., David G., Geijtenbeek T.B., Gallay P. Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc. Natl. Acad. Sci. USA 2007, 104(49):19464-19469.
14. de Witte L., Nabatov A., Geijtenbeek T.B. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol. Med. 2008, 14(1):12-19.
15. Du T., Hu K., Yang J., Jin J., Li C., Stieh D., Griffin G.E., Shattock R.J., Hu Q. Bifunctional CD4-DC-SIGN fusion proteins demonstrate enhanced avidity to gp120 and inhibit HIV-1 infection and dissemination. Antimicrob. Agents Chemother. 2012, 56(9):4640-4649.
16. Edwards J.N., Morris H.B. Langerhan[U+05F3]s cells and lymphocyte subsets in the female genital tract. Br. J. Obstet. Gynaecol. 1985, 92(9):974-982.
17. Eggink D., Melchers M., Wuhrer M., van Montfort T., Dey A.K., Naaijkens B.A., David K.B., Le Douce V., Deelder A.M., Kang K., Olson W.C., Berkhout B., Hokke C.H., Moore J.P., Sanders R.W. Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function. Virology 2010, 401(2):236-247.
18. Feinberg H., Guo Y., Mitchell D.A., Drickamer K., Weis W.I. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J. Biol. Chem. 2005, 280(2):1327-1335.
19. Ferrer M., Godbout K.L., Sullivan B.J., Austen D.A., Sanderson C.T., Kelley K.C., Osburne M.S., Harrison S.C., van Schravendijk M.R. Construction and characterization of a radio-iodinatable mutant of recombinant human CD4. J. Immunol. Methods 1997, 210(2):215-225.
20. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100(5):587-597.
21. Granelli-Piperno A., Moser B., Pope M., Chen D., Wei Y., Isdell F., O'Doherty U., Paxton W., Koup R., Mojsov S., Bhardwaj N., Clark-Lewis I., Baggiolini M., Steinman R.M. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J. Exp. Med. 1996, 184(6):2433-2438.
22. Gringhuis S.I., van der Vlist M., van den Berg L.M., den Dunnen J., Litjens M., Geijtenbeek T.B. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 2010, 11(5):419-426.
23. Gummuluru S., Rogel M., Stamatatos L., Emerman M. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J. Virol. 2003, 77(23):12865-12874.
24. Haase A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464(7286):217-223.
25. Harbury P.B., Zhang T., Kim P.S., Alber T. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science 1993, 262(5138):1401-1407.
26. Harman A.N., Kim M., Nasr N., Sandgren K.J., Cameron P.U. Tissue dendritic cells as portals for HIV entry. Rev. Med. Virol. 2013, 23(5):319-333.
27. Hodges A., Sharrocks K., Edelmann M., Baban D., Moris A., Schwartz O., Drakesmith H., Davies K., Kessler B., McMichael A., Simmons A. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat. Immunol. 2007, 8(6):569-577.
28. Hong P.W., Nguyen S., Young S., Su S.V., Lee B. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120. J. Virol. 2007, 81(15):8325-8336.
29. Hu J., Gardner M.B., Miller C.J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 2000, 74(13):6087-6095.
30. Hu K., Luo S., Tong L., Huang X., Jin W., Huang W., Du T., Yan Y., He S., Griffin G.E., Shattock R.J., Hu Q. CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissue. J. Immunol. 2013, 191(4):1935-1947.
31. Hu Q., Frank I., Williams V., Santos J.J., Watts P., Griffin G.E., Moore J.P., Pope M., Shattock R.J. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 2004, 199(8):1065-1075.
32. Hu Q., Huang X., Shattock R.J. C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors. J. Gen. Virol. 2010, 91(Pt 12):2965-2973.
33. Hu Q., Napier K.B., Trent J.O., Wang Z., Taylor S., Griffin G.E., Peiper S.C., Shattock R.J. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization. J. Mol. Biol. 2005, 350(4):699-712.
34. Hu Q.X., Barry A.P., Wang Z.X., Connolly S.M., Peiper S.C., Greenberg M.L. Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis. J. Virol. 2000, 74(24):11858-11872.
35. Huang X., Jin W., Hu K., Luo S., Du T., Griffin G.E., Shattock R.J., Hu Q. Highly conserved HIV-1 gp120 glycans proximal to CD4-binding region affect viral infectivity and neutralizing antibody induction. Virology 2012, 423(1):97-106.
36. Izquierdo-Useros N., Naranjo-Gomez M., Erkizia I., Puertas M.C., Borras F.E., Blanco J., Martinez-Picado J. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?. PLoS Pathog. 2010, 6(3):e1000740.
37. Keeffe J.R., Gnanapragasam P.N., Gillespie S.K., Yong J., Bjorkman P.J., Mayo S.L. Designed oligomers of cyanovirin-N show enhanced HIV neutralization. Proc. Natl. Acad. Sci. USA 2011, 108(34):14079-14084.
38. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., Sun C., Grayson T., Wang S., Li H., Wei X., Jiang C., Kirchherr J.L., Gao F., Anderson J.A., Ping L.H., Swanstrom R., Tomaras G.D., Blattner W.A., Goepfert P.A., Kilby J.M., Saag M.S., Delwart E.L., Busch M.P., Cohen M.S., Montefiori D.C., Haynes B.F., Gaschen B., Athreya G.S., Lee H.Y., Wood N., Seoighe C., Perelson A.S., Bhattacharya T., Korber B.T., Hahn B.H., Shaw G.M. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 2008, 105(21):7552-7557.
39. Lambert A.A., Azzi A., Lin S.X., Allaire G., St-Gelais K.P., Tremblay M.J., Gilbert C. Dendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitors. PLoS One 2013, 8(7):e67873.
40. Lambert A.A., Barabe F., Gilbert C., Tremblay M.J. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood 2011, 117(24):6589-6599.
41. Lambert A.A., Gilbert C., Richard M., Beaulieu A.D., Tremblay M.J. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 2008, 112(4):1299-1307.
42. + T cells. PLoS Pathog. 2010, 6(11):e1001188.
43. Lee R.T., Hsu T.L., Huang S.K., Hsieh S.L., Wong C.H., Lee Y.C. Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities. Glycobiology 2011, 21(4):512-520.
44. Liang Z., Guo Z., Wang X., Kong X., Liu C. Two retroviruses packaged in one cell line can combined inhibit the replication of HIV-1 in TZM-bl cells. Virol. Sin. 2012, 27(6):339-344.
45. Ma X., Cui H.Q., Yang T., Zhang Z.J. Expression, purification and biological analysis of soluble DC-SIGN. Chin. J. Microbiol. Immunol. 2004, 24:67-71.
46. Masurier C., Salomon B., Guettari N., Pioche C., Lachapelle F., Guigon M., Klatzmann D. Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J. Virol. 1998, 72(10):7822-7829.
47. McDonald D. Dendritic cells and HIV-1 trans-infection. Viruses 2010, 2(8):1704-1717.
48. Mesman A.W., Geijtenbeek T.B. Pattern recognition receptors in HIV transmission. Front. Immunol. 2012, 3:59.
49. Miller C.J., McChesney M., Moore P.F. Langerhans cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab. Invest. 1992, 67(5):628-634.
50. Nobile C., Petit C., Moris A., Skrabal K., Abastado J.P., Mammano F., Schwartz O. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 2005, 79(9):5386-5399.
51. Parrish N.F., Gao F., Li H., Giorgi E.E., Barbian H.J., Parrish E.H., Zajic L., Iyer S.S., Decker J.M., Kumar A., Hora B., Berg A., Cai F., Hopper J., Denny T.N., Ding H., Ochsenbauer C., Kappes J.C., Galimidi R.P., West A.P., Bjorkman P.J., Wilen C.B., Doms R.W., O'Brien M., Bhardwaj N., Borrow P., Haynes B.F., Muldoon M., Theiler J.P., Korber B., Shaw G.M., Hahn B.H. Phenotypic properties of transmitted founder HIV-1. Proc. Natl. Acad. Sci. USA 2013, 110:6626-6633.
52. Piguet V., Steinman R.M. The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol. 2007, 28(11):503-510.
53. Pohlmann S., Baribaud F., Doms R.W. DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol. 2001, 22(12):643-646.
54. Pokidysheva E., Zhang Y., Battisti A.J., Bator-Kelly C.M., Chipman P.R., Xiao C., Gregorio G.G., Hendrickson W.A., Kuhn R.J., Rossmann M.G. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 2006, 124(3):485-493.
55. Quinones-Kochs M.I., Buonocore L., Rose J.K. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response. J. Virol. 2002, 76(9):4199-4211.
56. Randolph G.J., Inaba K., Robbiani D.F., Steinman R.M., Muller W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999, 11(6):753-761.
57. Richard M., Thibault N., Veilleux P., Breton R., Beaulieu A.D. The ITIM-bearing CLECSF6 (DCIR) is down-modulated in neutrophils by neutrophil activating agents. Biochem. Biophys. Res. Commun. 2003, 310(3):767-773.
58. Rinaldo C.R. HIV-1 infection of CD4 T cells by professional antigen presenting cells. Scientifica 2013, 2013:164203.
59. Royce R.A., Sena A., Cates W., Cohen M.S. Sexual transmission of HIV. N. Engl. J. Med. 1997, 336(15):1072-1078.
60. Sarkar R., Mitra D., Chakrabarti S. HIV-1 gp120 protein downregulates Nef induced IL-6 release in immature dentritic cells through interplay of DC-SIGN. PLoS One 2013, 8(3):e59073.
61. Sneyd J.R. Off-label use of medicines is bad medicine flying the flag of clinical freedom. Int. J. Obstet. Anesth. 2009, 18(3):249-250.
62. Soilleux E.J., Morris L.S., Rushbrook S., Lee B., Coleman N. Expression of human immunodeficiency virus (HIV)-binding lectin DC-SIGNR: consequences for HIV infection and immunity. Hum. Pathol. 2002, 33(6):652-659.
63. Spira A.I., Marx P.A., Patterson B.K., Mahoney J., Koup R.A., Wolinsky S.M., Ho D.D. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 1996, 183(1):215-225.
64. Steinman R.M., Granelli-Piperno A., Pope M., Trumpfheller C., Ignatius R., Arrode G., Racz P., Tenner-Racz K. The interaction of immunodeficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 2003, 276:1-30.
65. Su S.V., Hong P., Baik S., Negrete O.A., Gurney K.B., Lee B. DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3. J. Biol. Chem. 2004, 279(18):19122-19132.
66. Taruishi M., Terashima K., Dewan Z., Yamamoto N., Ikeda S., Kobayashi D., Eishi Y., Yamazaki M., Furusaka T., Sugimoto M., Ishii M., Kitamura K. Role of follicular dendritic cells in the early HIV-1 infection: in vitro model without specific antibody. Microbiol. Immunol. 2004, 48(9):693-702.
67. Turville S., Wilkinson J., Cameron P., Dable J., Cunningham A.L. The role of dendritic cell C-type lectin receptors in HIV pathogenesis. J. Leukoc. Biol. 2003, 74(5):710-718.
68. Turville S.G., Arthos J., Donald K.M., Lynch G., Naif H., Clark G., Hart D., Cunningham A.L. HIV gp120 receptors on human dendritic cells. Blood 2001, 98(8):2482-2488.
69. Turville S.G., Santos J.J., Frank I., Cameron P.U., Wilkinson J., Miranda-Saksena M., Dable J., Stossel H., Romani N., Piatak M., Lifson J.D., Pope M., Cunningham A.L. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 2004, 103(6):2170-2179.
70. Valitutti S., Muller S., Cella M., Padovan E., Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995, 375(6527):148-151.
71. van den Berg L.M., Geijtenbeek T.B. Antiviral immune responses by human langerhans cells and dendritic cells in HIV-1 infection. Adv. Exp. Med. Biol. 2013, 762:45-70.
72. Wiley R.D., Gummuluru S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl. Acad. Sci. USA 2006, 103(3):738-743.
73. Wu L., KewalRamani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 2006, 6(11):859-868.
74. Wu L., Martin T.D., Carrington M., KewalRamani V.N. Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 2004, 318(1):17-23.
75. Zelensky A.N., Gready J.E. The C-type lectin-like domain superfamily. FEBS J. 2005, 272(24):6179-6217.